Accession Number: | 0000019446-19-000055 |
Date: | 2019-09-24 |
Issuer: | CANTEL MEDICAL CORP (CMD) |
Original Submission Date: |
DIKER CHARLES M
570 LEXINGTON AVE.
NEW YORK, NY 10022
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | M | 25,000 | a | $36.70 | 3,039,490 | direct | ||
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | F | 11,559 | d | $79.38 | 3,027,931 | direct | ||
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | F | 5,265 | d | $79.38 | 3,022,666 | direct | ||
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | 0 | $0.00 | 450,188 | indirect | ||||
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | 0 | $0.00 | 88,134 | indirect | ||||
COMMON STOCK, PAR VALUE $.10 PER SHARE | 2019-09-24 | 0 | $0.00 | 29,430 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 36.7 | 2019-09-24 | deemed execution date | M | 25,000 (d) | 2015-10-10 | 2019-10-09 | common stock, par value, $.10 per share 25,000 | $36.70 | 0 | direct |
ID | footnote |
---|---|
f1 | this stock option, granted under the issuer's 2006 equity incentive plan, was exercisable in three equal annual installments commencing on the first anniversary of the grant date. |